Muscle Development and Regeneration The nicotinamide adenine dinucleotide (NAD+)-dependent deacetylase SIRT1 been shown to control skeletal muscle differentiation in a cell culture system. SIRT1 forms a complex with the acetyltransferases PCAF and p300 and the developmental regulator MyoD and , when overexpressed, retards muscle differentiation. Conversely, cells with decreased SIRT1 protein levels or where the enzymatic activity of SIRT1 is specifically inhibited by pharmacological agents, differentiate prematurely. SIRT1 We propose to investigate whethe SIRT1 controls muscle differentiation in the animal. Muscle differentiation in vivo occurs during development, in the formation of new muscles, and in the adult, during regeneration following muscle injury. Understanding the role of SIRT1during muscle development and muscle regeneration, might have potentialy implication in the therapy of muscle wasting (i.e. muscle dystrophies, muscle healing following traumatic injuries, and sarcopenia of the elderly). Muscle Atrophy Skeletal muscle wasting and weakness (atrophy) is associated with numerous conditions, including the muscular dystrophies, disuse, burns, denervation, and cancer. A reduction of muscle mass and function is physiologically observed in the elderly (sarcopenia). As skeletal muscle mass is maintained through a balance of protein synthesis and degradation, a clearer understanding of these pathways may lead to novel treatment strategies for conditions where muscle wasting and weakness are indicated. Increased levels of the protein SIRT1 has previously been linked to increased lifespan in mice. In addition, SIRT1 has been found to decrease the expression of a number of proteins believed to be associated with skeletal muscle atrophy. However, no study to date has examined the role of SIRT1 in an animal model of muscle atrophy. The results from these experiments will provide novel and important results relating to the potential therapeutic applications of SIRT1 activation. Furthermore, these results will have implications for numerous conditions where muscle wasting and weakness are indicated.

Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Zip Code
Li, Haisen; Sartorelli, Vittorio (2018) ATP Citrate Lyase: A New Player Linking Skeletal Muscle Metabolism and Epigenetics. Trends Endocrinol Metab 29:202-204
Segatto, Marco; Fittipaldi, Raffaella; Pin, Fabrizio et al. (2017) Epigenetic targeting of bromodomain protein BRD4 counteracts cancer cachexia and prolongs survival. Nat Commun 8:1707
Park, Sung-Jun; Ahmad, Faiyaz; Um, Jee-Hyun et al. (2017) Specific Sirt1 Activator-mediated Improvement in Glucose Homeostasis Requires Sirt1-Independent Activation of AMPK. EBioMedicine 18:128-138
Jullien, Jerome; Vodnala, Munender; Pasque, Vincent et al. (2017) Gene Resistance to Transcriptional Reprogramming following Nuclear Transfer Is Directly Mediated by Multiple Chromatin-Repressive Pathways. Mol Cell 65:873-884.e8
Wang, A Hongjun; Juan, Aster H; Ko, Kyung Dae et al. (2017) The Elongation Factor Spt6 Maintains ESC Pluripotency by Controlling Super-Enhancers and Counteracting Polycomb Proteins. Mol Cell 68:398-413.e6
Juan, Aster H; Sartorelli, Vittorio (2016) S6K1ing to ResTOR Adipogenesis with Polycomb. Mol Cell 62:325-6
Juan, Aster H; Wang, Stan; Ko, Kyung Dae et al. (2016) Roles of H3K27me2 and H3K27me3 Examined during Fate Specification of Embryonic Stem Cells. Cell Rep 17:1369-1382
Feng, Xuesong; Juan, Aster H; Wang, Hongjun A et al. (2016) Polycomb Ezh2 controls the fate of GABAergic neurons in the embryonic cerebellum. Development 143:1971-80
Yang, Xiang-Ping; Jiang, Kan; Hirahara, Kiyoshi et al. (2015) EZH2 is crucial for both differentiation of regulatory T cells and T effector cell expansion. Sci Rep 5:10643
Ryall, James G; Cliff, Tim; Dalton, Stephen et al. (2015) Metabolic Reprogramming of Stem Cell Epigenetics. Cell Stem Cell 17:651-662

Showing the most recent 10 out of 20 publications